IDH2 and central nervous system cancer: Because the epigenetic changes occur in gliomas with IDH mutation via TET (Ten-eleven translocation) enzymes that catalyze a key step in the removal of DNA methylation, expression of several enzymes is altered, resulting in various metabolic changes17,18.